Quantinno Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Quantinno Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.31M	Buy	642,486 +5,392	+0.8%	+$72.7K	0.01%	1008
2026 Q1	$8.82M	Buy	637,094 +264,856	+71%	+$3.69M	0.01%	923
2025 Q4	$5.23M	Buy	372,238 +53,588	+17%	+$752K	0.01%	1022
2025 Q3	$4.45M	Buy	318,650 +83,606	+36%	+$1.2M	0.01%	953
2025 Q2	$3.53M	Buy	235,044 +112,988	+93%	+$1.61M	0.02%	934
2025 Q1	$1.61M	Buy	122,056 +14,867	+14%	+$205K	0.01%	1029
2024 Q4	$1.69M	Buy	107,189 +6,004	+6%	+$90.2K	0.02%	904
2024 Q3	$1.61M	Buy	101,185 +15,470	+18%	+$249K	0.02%	808
2024 Q2	$1.31M	Buy	85,715 +24,430	+40%	+$350K	0.02%	719
2024 Q1	$899K	Buy	61,285 +15,175	+33%	+$222K	0.02%	769
2023 Q4	$642K	Buy	46,110 +11,185	+32%	+$150K	0.02%	751
2023 Q3	$467K	Buy	34,925 +4,565	+15%	+$61.8K	0.02%	743
2023 Q2	$383K	Buy	30,360 +4,800	+19%	+$56K	0.02%	696
2023 Q1	$291K	Sell	25,560 -21,585	-46%	-$233K	0.02%	725
2022 Q4	$488K	Buy	+47,145	New	+$509K	0.04%	549

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Quantinno Capital Management's RDY Position: Q2 2026 in Review

Quantinno Capital Management increased its Dr. Reddy's Laboratories (RDY) stake by 0.85% in Q2 2026, buying an estimated $72.7K and bringing the position to 642,486 shares worth $9.31M. The position accounts for 0.01% of the portfolio, ranked #1008.

Quantinno Capital Management first reported a position in RDY in Q4 2022 and has held it in 15 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Quantinno Capital Management held 642,486 shares of Dr. Reddy's Laboratories worth $9.31M as of Q2 2026.
Quantinno Capital Management bought 5,392 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $72.7K.
Dr. Reddy's Laboratories made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1008 holding.
Quantinno Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 15 quarters since.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.